M.sub.2 receptor ligand for the treatment of neurological disord

Details M.sub.2 receptor ligand for the treatment of neurological disord M.sub.2 receptor ligand for the treatment of neurological disord

1995-01-24

1998-01-27

Bond, Robert T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

540495, A61K 3155, C07D47104

Patent

active

057122695

ABSTRACT:
Muscarinic M.sub.2 receptor ligands are described which are suitable for the treatment of neurological disorders, and which may be administered with minimal side-effects. A method of synthesis of these compounds is also described.

REFERENCES:
patent: 3406168 (1968-10-01), Schmidt
Engel et al., "Tricyclic Compounds as Selective Muscarinic Receptor Antagonists. 3. Structure-Activity Relationships in a Series of Cardioselective (M.sub.2) Antimuscarinics," J. Med. Chem., 32:1718-1724 (1989).
Karton et al., "Synthesis and Biological Activity of Some Methoctramine--Related Tetraamines Bearing a Antimuscarinics: A Second Generation of Highly Selective M.sub.2 Muscarinic Receptor Antagonists," J. Med. Chem., 34:2133-2145 (1991).
Melchiorre et al., "Functionalized Congener Approach to Muscarinic Antagonists: Analogues of Pirenzepine," J. Med. Chem., 36:3734-3737 (1993).
Doods et al., "Therapeutic Potential of CNS-Active M.sub.2 Antagonists Novel Structures and Pharmacology," Life Sciences, 52:497-503 (1993).
Aubert, I., et al., "Characterization and Autoradiographic Distribution of the Rat Brain," Eur. J. Pharmacol. 217(2/3):173-184 (Jul. 7, 1992).
Billard, W., et al., "Characterization of the Binding of .sup.3 H-SCH 23390, A Selective D-1 Receptor Antagonist Ligand, In Rat Striatum," Life Sci. 35(18):1885-1893 (1984).
Bonner, T.I., "The Molecular Basis of Muscarinic Receptor Diversity," TINS 12(4):148-151 (1989).
Buckley, N.J., et al., "Localization of a Family of Muscarinic Receptor mRNAs in Rat Brain," J. Neurosci. 8(12):4646-4652 (Dec. 1989).
Collerton, D., "Cholinergic Function and Intellectual Decline in Alzheimer's Disease," Neurosci. 19(1):1-28 (1986).
Dawson, V.L., et al., "Hippocampal Muscarinic Supersensitivity After AF64A Medial Septal Lesion Excludes M.sub.1 Receptors," Brain Res. Bull. 25:311-317 (Aug. 1990).
Dawson, V.L., et al., "Alteration in Cortical Muscarinic Receptors Following Cholinotoxin (AF64A) Lesion of the Rat Nucleus Basalis magnocellularis," Neurobiol. Aging 13(1):25-32 (1991).
Engel, G., et al., "Evidence for Common Pharmacological Properties of 5-Hydroxytryptamine Autoreceptors in CNS and Inhibitory Presynaptic 5-Hydroxytryptamine Receptors on Sympathetic Nerves," Naunyn Schmiedeberg's Arch. Pharmacol. 324(2):116-124 (1983).
Engel, W.W., et al., "Tricyclic Compounds as Selective Muscarinic Receptor Antagonists, 3, Structure-Selectivity Relationships in a Series of Cardioselective (M.sub.2) Antimuscarinics," J. Med. Chem. 32(8):1718-1724 (1989).
Entzeroth, M. and Mayer, N., "Labeling of Rat Heart Muscarinic Receptors Pharmacol. 40(7):1674-1676 (1990).
Glass, J.D., et al. "Benzyloxycarbonylarginine Nitrophenyl Ester Salts: 1-Hydroxybenzotriazole Catalyzed Acylations of Amines," Int. J. Peptide Protein Res. 12(2):75-80 (Aug. 1978).
Goldman, J., et al. "Aging of the Brain: Dementia of the Alzheimer's Type," Principles of Neural Science, 3rd Edition, ed. Kandel et al., Chapter 62 (Part X), 974-983 (Elsevier New York 1991).
Greenstein, J.P., et al., "Chemical Procedures for Synthesis of Peptides," Chemistry of the Amino Acids, vol. 2, 891-895, John Wiley and Sons, Inc. (New York 1961).
Hammer, R., et al., "Binding Profile of a Novel Cardioselective Muscarine Receptor Antagonist, AF-DX 116, to Membranes of Peripheral Tissues and Brain in the Rat," Life Sci. 38(18):1653-1662 (1986).
Hanisch, U.-K., et al., "Modulation of Hippocampal Acetylcholine Release: a Potent Central Action of Interleukin-2," J. Neurosci. 13(8):3368-3374 (Aug. 1993). AF-DX 116 on Endogenous Acetylcholine Release from Rat Brain Slices," Brain Res. 496(1/2):285-294 (Sep. 4, 1989).
Lee, K.S., et al. "1,3-Dipropyl-8-Cyclopentylxanthine (DPCPX) Inhibition of Visualization of Putative Non-A1 Adenosine Receptors," Brain Res. 368(2):394-398 (Mar. 19, 1986).
Liao, C.-F., et al. "Molecular Cloning and Expression of a Fifth Muscarinic Acetylcholine Receptor," J. Biol. Chem. 264(13):7328-7337 (May 5, 1989).
Lott, R.S., et al., "Trimethylsilyl Iodide as a Peptide Deblocking Agent," J.C.S. Chem. Commun. 495-496 (1979).
Lynch, C.J., et al., "Evidence for High and Low Affinity .alpha..sub.2 -Receptors," J. Biological Chem. 256(7):3298-3303 (Apr. 10, 1981).
Martin, B.R., et al., "Relationship of the Biodisposition of the Stereoisomers of Nicotine in the Central Nervous System to Their Pharmacological Actions," J. Pharmacol. Exper. Therapeu. 226(1):157-163 (Jul. 1983).
Mash, D.C., et al., "Loss of M2 Muscarine Receptors in the Cerebral Cortex in Alzheimer's Disease and Experimental Cholinergic Denervation," Science 288:1115-1117 (May 31, 1985).
McCabe, R.T., et al., "Characterization of Benzodiazepine Receptors with Fluorescent Ligands," FASEB J. 4:2934-2940 (Aug. 1990).
Michel, A.D., et al., "Direct Labeling of Rat M.sub.3 -Muscarinic Receptors
Morris, R.G.M., "Spatial Localization Does Not Require Presence of Local Cues," Learning and Motivation 12:239-260 (1981).
Pittel, Z., et al., "Distinct Muscarinic Receptor Subtypes Differentially Modulae Acetylcholine Release from Corticocerebral Synaptosomes," J. Neurochem. 55(2):665-672 (Aug. 1990).
Quirion, R., et al., "Muscarinic Receptor Subtypes in Human Neurodegenerative Disorders: Focus on Alzheimer's Disease," TIPS Suppl. 80-84 (Dec. 1989).
Sakahibara, S., et al., "A New Reagent for the p-Nitrophenylation of Carboxylic Acids," Bull. Chim. Soc. Jpn. 37(8):1231-1232 (Aug. 1964).
Sloan, J.W., et al., "The Comparative Binding Characteristics of Nicotinic Ligands and Their Pharmacology," Pharmacol. Biochem. Behav. 30(1):255-267 (May 1988).
Smith, G., "Animal Models for Alzheimer's Disease: Experimental Cholinergic Denervation," Brain Res. Rev. 13(2):103-118 (Apr./Jun. 1988).
Spencer, D.G., et al., "Direct Autoradiographic Determination of M1 and M2 Muscarinic Acetylcholine Receptor Distribution in the Rat Brain: Relation to Cholinergic Nuclei and Projections," Brain Res. 380(1):59-68 (Aug. 13, 1986). Striatal Synaptic Membranes," Neuroscience 6(3):407-410 (1981).
Yamamura, H.I., et al., (eds), In: Neurotransmitter Receptor Binding, 2nd ed., Raven Press, New York (1985).

Affiliated with

Also associated with

Rating

M.sub.2 receptor ligand for the treatment of neurological disord does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with M.sub.2 receptor ligand for the treatment of neurological disord, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and M.sub.2 receptor ligand for the treatment of neurological disord will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-342505